TOP STORIES

• BUSINESS Japan Likely to See Generic Listing for Azilva, Zytiga in 2023; Xarelto AG Rivals Too
  January 5, 2023

• TRENDS Top 10 PHARMA JAPAN Articles in 2022
  December 28, 2022

• REGULATORY PMDA Says “Slow Cartagena Review” Is Urban Legend, Set to Dispel Misconception
  December 27, 2022

• REGULATORY Japan Approves Sanofi’s PD-1 Inhibitor, Teikoku’s Donepezil Tape and More
  December 26, 2022

• BUSINESS Janssen Labor Union to Hold 1st Bargaining Session as Early as Jan. 11
  December 23, 2022

• REGULATORY Special PMP Increase to Offset 95% of Price Cuts for 150 Products: FY2023 Revision
  December 22, 2022

• BUSINESS Janssen Japan Employees Form Labor Union to Counter Closing of Positions
  December 21, 2022

• BUSINESS Kissei Won’t Change 2025 Targets Despite Linzagolix Setback, Decide US Plan by March
  December 20, 2022

• BUSINESS Pharma Industry Mixed on Off-Year Drug Price Revision Plan for FY2023
  December 19, 2022

• REGULATORY Chuikyo OKs FY2023 Price Revision Outline Specifying “0.625 Times” Product Coverage Threshold
  December 19, 2022

• REGULATORY Ministers Agree on “4.375%” Product Coverage Line for 2023 “Off-Year” Drug Price Revision
  December 16, 2022

• REGULATORY Off-Year Re-Pricing Expected to Cover 70% of Listed Products; Special Steps for Unprofitable Drugs, Patented Meds
  December 16, 2022

• BUSINESS Takeda’s HAE Drug Takhzyro Enjoying Positive Uptake in Japan: Exec
  December 15, 2022

• BUSINESS Total Sales of 25 Japan Drug Makers Up 12.9% in 1st Half, Global Players Fare Well While SMEs Falter
  December 15, 2022

• REGULATORY Japan to Refit R&D Tax Credit System to Boost Incentive; Lower Minimum Deduction Rate, Variable Cap
  December 14, 2022

• REGULATORY Japan Govt to Purchase Another 1 Million Courses of Xocova
  December 14, 2022

• COMMENTARY LDP Expects to Finalize Tax Reform Plan This Week; Will It Expand R&D Credit System?
  December 13, 2022

• REGULATORY 70% of Listed Meds Likely to Face Off-Year Re-Pricing If Prior Threshold Applied: MHLW
  December 12, 2022

• BUSINESS CSL to Bring 1st Hemophilia B Gene Therapy to Japan Too; Eyes Riveted on Price Tag
  December 9, 2022

• BUSINESS Merck CEO Wants to See Japan’s Shift to Pro-Innovation Structure in 2024 Reform
  December 9, 2022

ページ

• « 先頭
• ‹ Prev
• …
• 56
• 57
• 58
• 59
• 60
• 61
• 62
• 63
• 64
• …
• Next ›
• 最終 »